Serialized ePedigree: From Planning to Execution - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Serialized ePedigree: From Planning to Execution
California's ePedigree requirements call for item-level serialization beginning in 2011. The author explains factors to consider when implementing a serialization strategy and how to achieve a positive return on investment.


Pharmaceutical Technology


Identifying and achieving ROI

Many companies may find a serialization solution to be yet one more cost of doing business. If implemented properly, however, it actually helps improve the business operation and bottom line. In a July 2008 report from Forrester Research, analysts outlined key benefits and gains of creating supply chain visibility (2). According to the report, the types of benefits will vary depending on the level of tagging (i.e., pallet-, case-, and/or item-level tags) and supply-chain stage. The scale, timing, and duration of these benefits can be estimated by considering one or more key metrics and the value of improving those metrics over time. Benefits include reduction in recalls and returns, reduction in shipping errors, improved financial accuracy of order terms, direct labor savings, reduction in inventory shrinkage, reduced losses due to expiration or spoilage, reduced stock-outs, and inventory cost savings. A well-executed implementation, integrated with existing business and enterprise resource planning systems, provides a real opportunity to further automate and improve distribution processes and realize a positive return on investment.

Going forward

California is one of the largest markets for pharmaceutical manufacturers. While other states have implemented similar, and less extensive measures, California is likely to have a greater impact on the pharmaceutical supply chain at the national level. The key to making the transition for manufacturing and information technology operations as seamless as possible is not to wait for standards. Industry consensus on technology and data constructs is lacking. Thinking strategically as to how serialization will affect the entire enterprise, while roping trading partners into this process, will help define future business implications. It is important to be cautious, but even more important to act early to implement a system that not only complies with state and future federal mandates, but also offers overall business value.

Andre Pino is the vice-president and chief marketing officer at Acsis, 3000 Lincoln Drive East, Marlton, NJ 08053, tel. 856.673.3000,

References

1. G.M. Gaul and M.P. Flaherty, "Lax system allows criminals to invade the supply chain," Wash. Post, Oct. 22, 2003.

2. R.C. Wildeman and P.M. Connaughton, "The ROI Of RFID For Supply Chain Visibility," Forrester Research, July 18, 2008.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here